Akoya Biosciences Inc (NAS:AKYA)
$ 2.5 -0.05 (-1.96%) Market Cap: 126.39 Mil Enterprise Value: 165.50 Mil PE Ratio: 0 PB Ratio: 9.11 GF Score: 46/100

Akoya Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2022 / 02:00PM GMT
Release Date Price: $11.98 (-6.41%)
Ruizhi Qin
JPMorgan Chase & Co, Research Division - Analyst

All right. Good morning, everyone. Welcome to day 4 of the JPMorgan Healthcare Conference. This is Julia Qin from the Life Science team at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Akoya.

Just a reminder, if you have a question, you can submit it through the website.

And with that, let me turn it over to Brian.

Brian McKelligon
Akoya Biosciences, Inc. - President, CEO & Director

Thank you, Julia. Good morning, everyone. And again, thanks to Julia, the entire JPMorgan team and to all of you for your time this morning.

Maybe before we get started, just a quick reminder on the necessary disclaimers. This slide will be up on our website if you'd like to review it in more detail.

Maybe just at the highest level before we dig in a little bit. As a company, 100% dedicated to the spatial biology revolution. It's really quite exciting to see how spatial biology is not only transforming discovery research but also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot